Alkermes (ALKS) EBITDA Margin (2010 - 2026)
Alkermes (ALKS) reported EBITDA Margin of 170.35% for Q1 2026, down 17785.0% year-over-year from N/an in Q1 2025, and down 1456.26% quarter-over-quarter from 12.56% in Q4 2025.
Alkermes (ALKS) EBITDA Margin (2010 - 2026) Analysis & Trends
Alkermes (ALKS) has 17 years of EBITDA Margin data on file, last reported at 170.35% in Q1 2026.
- EBITDA Margin for Q1 2026 came in at 170.35%, down 17785.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 12.51% (down 1093.0% YoY), and the FY2025 annual result was 16.37%, down 727.0% from the prior year.
- EBITDA Margin retreated to 170.35% in Q1 2026 per ALKS's latest filing, from 12.56% in the prior quarter.
- Over five years, EBITDA Margin peaked at 38.51% in Q2 2023 and troughed at 2072.59% in Q3 2022.
- A 5-year average of 179.65% and a median of 12.56% in 2025 frame the typical range for EBITDA Margin.
- The sharpest annual moves came in 2022 and 2023: EBITDA Margin sank 206265 bps in 2022, then surged 208549 bps in 2023.
- A 5-year view of EBITDA Margin shows it stood at 8.63% in 2022, then surged by 455 bps to 30.66% in 2023, then increased by 9 bps to 33.52% in 2024, then sank by 63 bps to 12.56% in 2025, then plunged by 1456 bps to 170.35% in 2026.
- Business Quant data shows ALKS's EBITDA Margin at 170.35% in Q1 2026, 12.56% in Q4 2025, and 21.08% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 16.37% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 36.83% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 41.69% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -1.01% |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 22.74% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 22.39% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -170.35% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 21.55% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -16.25% |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 46.29% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -170.35% |
| Dec 31, 2025 | 12.56% |
| Sep 30, 2025 | 21.08% |
| Jun 30, 2025 | 22.31% |
| Mar 31, 2025 | 7.50% |
| Dec 31, 2024 | 33.52% |
| Sep 30, 2024 | 25.49% |
| Jun 30, 2024 | 22.89% |
| Mar 31, 2024 | 10.37% |
| Dec 31, 2023 | 30.66% |
| Sep 30, 2023 | 12.89% |
| Jun 30, 2023 | 38.51% |
| Mar 31, 2023 | -13.59% |
| Dec 31, 2022 | -8.63% |
| Sep 30, 2022 | -2,072.59% |
| Jun 30, 2022 | -1,012.19% |
| Mar 31, 2022 | -14.51% |
| Dec 31, 2021 | -0.12% |
| Sep 30, 2021 | -9.94% |
| Jun 30, 2021 | 0.69% |